| Staurosporine | IC50 | 0.41 [1], 4.72 [2] |
| Su6656 | IC50 | 110.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| JNK Inhibitor VIII | Ki | 8800.0 [1] |
| 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 22.0 [1] |
| Cep-11981 | IC50 | 21.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 8800.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 8800.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| 5-(4-Chlorophenyl)-N-(4-piperazin-1-ylphenyl)furan-2-carboxamide | IC50 | 30000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8800.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 8800.0 [1] |
| Ripk1-IN-7 | IC50 | 50.0 [1] |
| 3-Methyl-N-[6-methylsulfanyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 10000.0 [1] |
| CID 27666048 | IC50 | 100000.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 570.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 650.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| CID 71553154 | IC50 | 470.0 [1] |
| 3-[5-Chloro-4-[(2,4-difluorophenyl)methoxy]-6-oxopyrimidin-1-yl]-N-(2-hydroxyethyl)-4-methylbenzamide | IC50 | 10000.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 10000.0 [1] |
| 2-[3-[3-(4-Methylpiperazin-1-yl)propoxy]phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 10000.0 [1] |
| 3-[4-[(2S)-2-(5-Methyl-1,2,4-oxadiazol-3-yl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 795.0 [1] |
| 3-[4-(2,3,3a,4,6,6a-Hexahydrofuro[2,3-c]pyrrol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 626.0 [1] |
| 2-[Ethyl-[[5-[[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-1,2-thiazol-3-yl]methyl]amino]ethanol | IC50 | 500.0 [1] |
| 2-(5-Methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-ylpyridin-3-yl)-1,3-thiazole-4-carboxamide | IC50 | 2100.0 [1] |
| N-[6-Methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-(pyridin-2-ylmethyl)-1,2-thiazol-5-amine | IC50 | 500.0 [1] |
| 3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-5-[[(4-methylsulfonylphenyl)methylamino]methyl]benzoic acid | IC50 | 30000.0 [1] |
| 5-[[[(2S)-2,4-Diamino-4-oxobutanoyl]amino]methyl]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid | IC50 | 6000.0 [1] |
| 3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-5-[(E)-[[5-(hydroxymethyl)furan-2-carbonyl]hydrazinylidene]methyl]benzoic acid | IC50 | 30000.0 [1] |
| 5-[(E)-[[2-(4-Chlorophenyl)sulfonylacetyl]hydrazinylidene]methyl]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid | IC50 | 30000.0 [1] |
| Aurora inhibitor 1 | IC50 | 1000.0 [1] |
| 3-[Dideuterio-(3,3-difluoropyrrolidin-1-yl)methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;hydrochloride | IC50 | 100.0 [1] |
| N-[5-[6-(Methylamino)pyrazin-2-yl]-2-oxo-1H-pyridin-3-yl]-4-[(2S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]benzamide | Ki | 1000.0 [1] |
| 2-(4-Chlorophenyl)-8-piperazin-1-yl-5-[(2-pyridin-3-ylphenyl)methyl]-10H-furo[2,3-c][1]benzazepin-4-one | IC50 | 12000.0 [1] |
| 3-[(3,3-Difluoropyrrolidin-1-yl)methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;hydrochloride | IC50 | 100.0 [1] |
| SCH-1473759 (hydrochloride) | IC50 | 100.0 [1] |
| (3R)-1-[2-[4-(4-Acetylphenyl)piperazin-1-yl]-2-oxoethyl]-N-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide | IC50 | 30000.0 [1] |
| 3-(Tert-butylamino)-4-[[2-(4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione | Ki | 2900.0 [1] |
| 2-(3,5-Dichloroanilino)-4-[[4-(dimethylamino)cyclohexyl]amino]-N-(1-methylpiperidin-4-yl)pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 2-(3,5-Dichloroanilino)-4-[[(3R,4S)-4-hydroxyoxolan-3-yl]amino]-N-(1-methylpiperidin-4-yl)pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 3-{4-[(2S)-2-Methylmorpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile | IC50 | 179.0 [1] |
| 3-[4-[2-(3-Methyl-1,2,4-oxadiazol-5-yl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 2388.0 [1] |
| 4-[5-(3-Cyanophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine-2-carbonitrile | IC50 | 288.0 [1] |
| 3-[4-[2-(1,2-Oxazol-5-yl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 1333.0 [1] |
| 3-[4-[2-(Cyanomethyl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 196.0 [1] |
| 3-[4-[(2R)-2-(5-Methyl-1,2,4-oxadiazol-3-yl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | IC50 | 3239.0 [1] |
| 1-[4-[2-[5-(4-Chlorophenyl)furan-2-yl]imidazol-1-yl]phenyl]piperazine | IC50 | 30000.0 [1] |